scholarly journals Variation in Plasma RNA Levels, CD4 Cell Counts, and p24 Antigen Levels in Clinically Stable Men with Human Immunodeficiency Virus Infection

1996 ◽  
Vol 174 (1) ◽  
pp. 191-194 ◽  
Author(s):  
J. M. Raboud ◽  
J. S. G. Montaner ◽  
B. Conway ◽  
L. Haley ◽  
C. Sherlock ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
P24 Antigen ◽  
Cd4 Cell ◽  
Plasma Rna ◽  
Rna Levels

Relationship of the Manifestations of Tuberculosis to CD4 Cell Counts in Patients with Human Immunodeficiency Virus Infection

1993 ◽  
Vol 148 (5) ◽  
pp. 1292-1297 ◽  
Author(s):  
Brenda E. Jones ◽  
Summer M. M. Young ◽  
Diana Antoniskis ◽  
Paul T. Davidson ◽  
Françoise Kramer ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
Relationship Of ◽  
Cd4 Cell

scholarly journals Effect of Oral β‐Carotene Supplementation on Plasma Human Immunodeficiency Virus (HIV) RNA Levels and CD4+ Cell Counts in HIV‐Infected Patients

1998 ◽  
Vol 27 (5) ◽  
pp. 1311-1313 ◽  
Author(s):  
Ajani P. Nimmagadda ◽  
Betty J. Burri ◽  
T. Neidlinger ◽  
William A. O'Brien ◽  
Matthew Bidwell Goetz
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hiv Rna ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
Cd4 Cell ◽  
Β Carotene ◽  
Rna Levels

scholarly journals Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals.

1996 ◽  
Vol 40 (11) ◽  
pp. 2664-2668 ◽  
Author(s):  
A M Been-Tiktak ◽  
I Williams ◽  
H M Vrehen ◽  
J Richens ◽  
D Aldam ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Transcriptase Inhibitor ◽  
Viral Loads ◽  
Nonnucleoside Reverse Transcriptase Inhibitor ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
Reverse Transcriptase Inhibitor ◽  
Cd4 Cell ◽  
Hiv 1

Atevirdine is a nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). In this study we investigated the effect of atevirdine in asymptomatic antiretroviral naive HIV-infected patients with CD4+ cell counts of between 200 and 750 cells per mm3. Patients were randomized to receive 600 mg of atevirdine (n = 15) or a placebo (n = 15) three times a day for 12 weeks. There was no statistically significant effect of atevirdine on viral loads (HIV p24 antigen and HIV-1 RNA levels by PCR) or CD4+ cell counts. The data do not support the use of atevirdine as a monotherapy in the treatment of HIV-infected patients.

Sign in / Sign up

Export Citation Format

Share Document